SL, N., Z, Z., TW, R., R, N., BM, S., D, H., & JS, M. (2022). Lipidomics of cyclophosphamide 4-hydroxylation in patients receiving post-transplant cyclophosphamide. Clinical and translational science, 15(11), 2772. https://doi.org/10.1111/cts.13404
Chicago Style (17th ed.) CitationSL, Navarro, Zheng Z, Randolph TW, Nakamura R, Sandmaier BM, Hockenbery D, and McCune JS. "Lipidomics of Cyclophosphamide 4-hydroxylation in Patients Receiving Post-transplant Cyclophosphamide." Clinical and Translational Science 15, no. 11 (2022): 2772. https://doi.org/10.1111/cts.13404.
MLA (9th ed.) CitationSL, Navarro, et al. "Lipidomics of Cyclophosphamide 4-hydroxylation in Patients Receiving Post-transplant Cyclophosphamide." Clinical and Translational Science, vol. 15, no. 11, 2022, p. 2772, https://doi.org/10.1111/cts.13404.